Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: A multicentre randomized trial

Human Reproduction

Volumn 22, Issue 2, 2007, Pages 500-505

  Crosignani, Piergiorgio G ^a   Somigliana, E ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

GnRH antagonist; Intrauterine insemination; Mild ovarian hyperstimulation

Indexed keywords

CHORIONIC GONADOTROPIN; GANIRELIX; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; INFERTILITY; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MENSTRUAL CYCLE; MULTICENTER STUDY; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

EID: 33846466750     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del416     Document Type: Article

References (35)

1. Aboulghar MA and Mansour RT (2003) Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 9,275-289.
2. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A and Devroey P (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67,917-922.
3. Albano C, Smitz J, Tournaye H, Riethmuller-Winzen H, Van Steirteghem A and Devroey P (1999) Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/ intracytoplasmic sperm injection cycles. Hum Reprod 14,1426-1430.
4. Checa MA, Prat M, Robles A and Carreras R (2006) Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertil Steril 85,573-577.
5. Cohlen BJ (2005) Should we continue performing intrauterine inseminations in the year 2004? Gynecol Obstet Invest 59,3-13.
6. Cohlen BJ, Vanderkerckhove P, Te Velde ER and Habbema JD (2001) Timed intercourse versus intra-uterine insemination with or without ovarian hyperstimulation for subfertility in men (Cochrane review). In The Cochrane Library, Issue 2, 2001. Update Software, John Wiley & Sons, Ltd., Oxford.
7. Collins J (2003) Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. Current best evidence for the advanced treatment of unexplained subfertility. Hum Reprod 18,907-912.
8. Crosignani PG and Rubin BL (2000) Optimal use of infertility diagnostic tests and treatments. The ESHRE Capri Workshop Group. Hum Reprod 15,723-732.
9. De Jong D, Macklon NS and Fauser BC (2000) A pilot study involving minimal ovarian stimulation for in vitro fertilization: Extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 73,1051-1054.
10. Dickey RP, Taylor SN, Lu PY, Sartor BM, Rye PH and Pyrzak R (2005) Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: Results of 4,062 intrauterine insemination cycles. Fertil Steril 83,671-683.
11. Dodson WC, Walmer DK, Hughes CL Jr, Yancy SE and Haney AF (1991) Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women. Obstet Gynecol 78,187-190.
12. Edwards RG (2003) Towards single births after assisted reproduction treatment. Reprod Biomed Online 7,506-508.
13. ESHRE Capri Workshop Group (2000) Multiple gestation pregnancy. Hum Reprod 15,1856-1864.
14. ESHRE Capri Workshop Group (2004) Diagnosis and management of the infertile couple: Missing information. Hum Reprod Update 10,295-307.
15. Fauser BC, Devroey P and Macklon NS (2005) Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365,1807-1816.
16. Gleicher N, Oleske DM, Tur-Kaspa I, Vidali A and Karande V (2000) Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins. N Engl J Med 343,2-7.
17. Gomez-Palomares JL, Julia B, Acevedo-Martin B, Martinez-Burgos M, Hernandez ER and Ricciarelli E (2005) Timing ovulation for intrauterine insemination with a GnRH antagonist. Hum Reprod 20,368-372.
18. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF and Schoemaker J (2000) Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomised trial and cost-effectiveness analysis. Lancet 355,13-18.
19. Guzick DS, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST et al. (1999) Efficacy of superovulation and intrauterine insemination in the treatment of infertility. Natl Cooperative Reprod Med Network. N Engl J Med 340,177-183.
20. Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, Carson SA, Cisneros P, Steinkampf MP, Hill JA et al. (2001) Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 345,1388-1393.
21. Hughes EG (2003) Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. 'Effective treatment' or 'not a natural choice'? Hum Reprod 18,912-914.
22. Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC and Devroey P (2003) Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 80,464-466.
23. Kurinczuk JJ (2003) Safety issues in assisted reproduction technology. From theory to reality-just what are the data telling us about ICSI offspring health and future fertility and should we be concerned? Hum Reprod 18,925-931.
24. Lambalk CB, Leader A, Olivennes F, Fluker MR, Andersen AN, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R et al. (2006) Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: Results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 21,632-639.
25. Papageorgiou TC, Guibert J, Savale M, Goffinet F, Fournier C, Merlet F, Janssens Y and Zorn JR (2004) Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. Br J Obstet Gynaecol 111,1277-1282.
26. Pritts EA and Atwood AK (2002) Luteal phase support in infertility treatment: A meta-analysis of the randomized trials. Hum Reprod 17,2287-2299.
27. Ragni G, Vegetti W, Baroni E, Colombo M, Arnoldi M, Lombroso G and Crosignani PG (2001) Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist. Hum Reprod 16,2258-2262.
28. Ragni G, Caliari I, Nicolosi AE, Arnoldi M, Somigliana E and Crosignani PG (2006) Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years' experience using low-dose recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 85,619-624.
29. Sengoku K, Tamate K, Takaoka Y, Morishita N and Ishikawa M (1994) A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility. Hum Reprod 9,1043-1047.
30. Stewart JA (2003) Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. Should the guidelines be changed? Hum Reprod 18,903-907.
31. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K and Devroey P (2006) GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 12,333-340.
32. Tur R, Barri PN, Coroleu B, Buxaderas R, Martinez F and Balasch J (2001) Risk factors for high-order multiple implantation after ovarian stimulation with gonadotrophins: Evidence from a large series of 1878 consecutive pregnancies in a single centre. Hum Reprod 16,2124-2129.
33. Tur R, Barri PN, Coroleu B, Buxaderas R, Parera N and Balasch J (2005) Use of a prediction model for high-order multiple implantation after ovarian stimulation with gonadotropins. Fertil Steril 83,116-121.
34. WHO (World Health Organization) (1999) Laboratory Manual for the Examination of Human Semen and Semen Cervical Mucus Interaction. Cambridge University Press, Cambridge.
35. Williams RS, Hillard JB, De Vane G, Yeko T, Kipersztok S, Rhoton-Vlasak A and Sistrom C (2004) A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. Am J Obstet Gynecol 191,648-651.